TIKTOK SETTLES ALABAMA CHILD SAFETY SUIT
Alabama’s lawsuit accused TikTok of designing features that knowingly endangered minors, including addictive algorithms and inadequate age v...
Status Summary: Contextual analysis of live event stream.
Pfizer reported lower-than-expected neutralizing antibody levels for its Q4 2023 COVID‑19 booster in early-phase data.
Resolution: The company reformulated the booster, secured emergency use authorization in early 2024, and restored market confidence.
Amgen postponed the final analysis of its PCSK9 inhibitor's cardiovascular outcomes trial after an interim safety signal.
Resolution: A revised protocol was submitted to the FDA, the trial resumed in Q3 2024, and the drug ultimately received label expansion.
Eli Lilly's obesity drug Mounjaro faced a split advisory committee vote due to concerns over long‑term cardiovascular risk data.
Resolution: Additional post‑marketing study commitments were accepted, and the drug received approval with risk‑evaluation conditions in early 2026.
Alabama’s lawsuit accused TikTok of designing features that knowingly endangered minors, including addictive algorithms and inadequate age v...
Media enterprise ESPN has deployed live coverage for the National Football League regular-season matchup featuring the Houston Texans agains...
Oil markets reacted swiftly on July 20, 2026, as Iran's president announced that Tehran might engage in direct negotiations with Washington,...
The Nasdaq 100 index, a benchmark for technology‑heavy equities, showed a measurable bounce on Friday after enduring its steepest decline in...
Jersey Mike's, the fast‑growth sub‑sandwich franchise, entered the public market at a $23 per share price, only to see its equity slide 2% i...